Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > New Poll on Shares Represented by this Board

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Apr 19, 2021 9:19am

108 Views

Post# 33020981

RE:RE:New Poll on Shares Represented by this Board

That number appears to be inflated!
I assume it includes Spceo s fund and that would mean an average of over 1 million shares for the other 15 responders

longterm56 wrote: Reposting this to keep it toward the top of the board ... we are already @ 23,952,182 shares with only 16 responses!

-LT

longterm56 wrote: Send an e-mail to anonymous0126@yahoo.com with the subject line as:

"THTX Shares: nnnn"

where nnnn is the # of shares you can influence. I'll tally the results and post them here. I promise I will not use or sell your e-mail address ;)

-LT